Withdrawn application: Adcetris, 23/02/2024
Withdrawn application: Adcetris, 23/02/2024
Withdrawn application: Adcetris, 23/02/2024
Quarterly System Demo – Q2 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2024, 09:00 (CEST) to 26 June 2024, 13:30 (CEST)
Q&A - Quarterly System Demo Q2 2024
Human medicines European public assessment report (EPAR): Agilus, dantrolene sodium, hemiheptahydrate, Date of authorisation: 29/05/2024, Status: Authorised
CTIS newsflash - 12 July 2024
Abecma / Breyanzi / Carvykti / Kymriah / Tecartus / Yescarta
Data access to medicinal products for human use - Chapter 5 Annex A: Product data elements accessible by stakeholder group
Committee for Orphan Medicinal Products (COMP): 21-23 May 2024, European Medicines Agency, Amsterdam, the Netherlands, from 21 May 2024 to 23 May 2024
Minutes of the COMP meeting 21-23 May 2024
Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa